Clinical Trial Update: Study of NKTR 255 in Combination With Cetuximab in Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study evaluating NKTR-255 in combination with cetuximab in solid tumors, including head and neck squamous cell carcinoma and colorectal cancer, has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Cetuximab (cetuximab)
• NKTR-255 (NKTR-255)

Snippet

Sponsor: Nektar Therapeutics | Conditions: Head and Neck Squamous Cell Carcinoma, Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-06-08